Sweden · Delayed Price · Currency is SEK KDventures AB Company Description
KDventures AB, formerly known as Karolinska Development AB (publ), is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, innovative drug development, drug delivery technologies, biotechnology, and life science tools and service sectors.
The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark.
It prefers to be a lead investor in its portfolio companies however does consider co-investments also.
It seeks to invest in up to five projects annually. KDventures AB was founded in 2003 and is based in Solna, Sweden with an additional office in Solna Sweden.
| Country | Sweden |
| Founded | 2003 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 7 |
| CEO | Viktor Drvota |
Contact Details
Address: Nanna Svartz väg 6A Solna, 17165 Sweden | |
| Phone | 46 8 52 48 60 70 |
| Website | karolinskadevelopment.com |
Stock Details
| Ticker Symbol | KDV.B |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Johan Dighed | Chief Legal Officer and Deputy Chief Executive Officer |
| Dr. Viktor Drvota M.D., Ph.D. | Chief Executive Officer |
| Hans Christopher Toll | Chief Financial Officer |
| Eva Montgomerie | Head of Accounting |
| Dr. John Öhd M.D., Ph.D. | Chief Scientific Officer and Venture Partner |
| Tse Ping | Senior Strategic Advisor |
| Mathias Frenzel | Investment Analyst |